% alzhub.org library filter
% Source: https://alzhub.org/research?author=Barkhof+F&score_min=67
% 7 entries, in the order the page lists them. Built from alzhub.org's own records.
% 0 entries have no readable author in the source record and carry no author field.

@article{salloway2022-34807243,
  author  = {Salloway, S. and Chalkias, S. and Barkhof, F. and Burkett, P. and Barakos, J. and Purcell, D. and Suhy, J. and Forrestal, F. and others},
  title   = {{Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease}},
  journal = {JAMA neurology},
  year    = {2022},
  doi     = {10.1001/jamaneurol.2021.4161},
  pmid    = {34807243},
  url     = {https://doi.org/10.1001/jamaneurol.2021.4161}
}

@article{buddhaeberlein2022-35542991,
  author  = {Budd Haeberlein, S. and Aisen, P. S. and Barkhof, F. and Chalkias, S. and Chen, T. and Cohen, S. and Dent, G. and Hansson, O. and others},
  title   = {{Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease}},
  journal = {The journal of prevention of Alzheimer's disease},
  year    = {2022},
  doi     = {10.14283/jpad.2022.30},
  pmid    = {35542991},
  url     = {https://doi.org/10.14283/jpad.2022.30}
}

@article{ostrowitzki2017-29221491,
  author  = {Ostrowitzki, S. and Lasser, R. A. and Dorflinger, E. and Scheltens, P. and Barkhof, F. and Nikolcheva, T. and Ashford, E. and Retout, S. and others},
  title   = {{A phase III randomized trial of gantenerumab in prodromal Alzheimer's disease}},
  journal = {Alzheimer's research \& therapy},
  year    = {2017},
  doi     = {10.1186/s13195-017-0318-y},
  pmid    = {29221491},
  url     = {https://doi.org/10.1186/s13195-017-0318-y}
}

@article{ketter2017-28269765,
  author  = {Ketter, N. and Brashear, H. R. and Bogert, J. and Di, J. and Miaux, Y. and Gass, A. and Purcell, D. D. and Barkhof, F. and others},
  title   = {{Central Review of Amyloid-Related Imaging Abnormalities in Two Phase III Clinical Trials of Bapineuzumab in Mild-To-Moderate Alzheimer's Disease Patients}},
  journal = {Journal of Alzheimer's disease : JAD},
  year    = {2017},
  doi     = {10.3233/jad-160216},
  pmid    = {28269765},
  url     = {https://doi.org/10.3233/jad-160216}
}

@article{altomare2023-37155177,
  author  = {Altomare, D. and Barkhof, F. and Caprioglio, C. and Collij, L. E. and Scheltens, P. and Lopes Alves, I. and Bouwman, F. and Berkhof, J. and others},
  title   = {{Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial}},
  journal = {JAMA neurology},
  year    = {2023},
  doi     = {10.1001/jamaneurol.2023.0997},
  pmid    = {37155177},
  url     = {https://doi.org/10.1001/jamaneurol.2023.0997}
}

@article{ostrowitzki2012-21987394,
  author  = {Ostrowitzki, S. and Deptula, D. and Thurfjell, L. and Barkhof, F. and Bohrmann, B. and Brooks, D. J. and Klunk, W. E. and Ashford, E. and others},
  title   = {{Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab}},
  journal = {Archives of neurology},
  year    = {2012},
  doi     = {10.1001/archneurol.2011.1538},
  pmid    = {21987394},
  url     = {https://doi.org/10.1001/archneurol.2011.1538}
}

@article{vanloenhoud2019-31266904,
  author  = {van Loenhoud, A. C. and van der Flier, W. M. and Wink, A. M. and Dicks, E. and Groot, C. and Twisk, J. and Barkhof, F. and Scheltens, P. and others},
  title   = {{Cognitive reserve and clinical progression in Alzheimer disease: A paradoxical relationship}},
  journal = {Neurology},
  year    = {2019},
  doi     = {10.1212/wnl.0000000000007821},
  pmid    = {31266904},
  url     = {https://doi.org/10.1212/wnl.0000000000007821}
}